DrugsControl Media Services

News Detail

Many approved cancer drugs lack proof of added benefit: Study (01-03-2024)

Netherlands, 1 March 2024: Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved through expedited ("fast track") pathways, finds a study published by The BMJ today.

View Details

Source : News Medical Net
Cancer Drugs Oncology Research

Related News